NL6909100A - - Google Patents
Info
- Publication number
- NL6909100A NL6909100A NL6909100A NL6909100A NL6909100A NL 6909100 A NL6909100 A NL 6909100A NL 6909100 A NL6909100 A NL 6909100A NL 6909100 A NL6909100 A NL 6909100A NL 6909100 A NL6909100 A NL 6909100A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB28528/68A GB1279402A (en) | 1968-06-14 | 1968-06-14 | Improvements in or relating to cephalosporin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL6909100A true NL6909100A (de) | 1969-12-16 |
Family
ID=10277067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL6909100A NL6909100A (de) | 1968-06-14 | 1969-06-13 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3647788A (de) |
| AT (2) | AT306231B (de) |
| BE (1) | BE734533A (de) |
| DE (1) | DE1930118A1 (de) |
| FR (1) | FR2010920A1 (de) |
| GB (1) | GB1279402A (de) |
| IE (1) | IE33997B1 (de) |
| NL (1) | NL6909100A (de) |
| ZA (1) | ZA694201B (de) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5248996B1 (de) * | 1971-01-29 | 1977-12-14 | Glaxo Lab Ltd | |
| JPS531280B1 (de) * | 1971-05-14 | 1978-01-17 |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE759570A (fr) * | 1969-11-28 | 1971-05-27 | Ciba Geigy | Derives de l'acide 7-cyanacetylamino-cephalosporanique et procede pour leur preparation |
| JPS4948559B1 (de) * | 1970-11-10 | 1974-12-21 | ||
| CS183696B2 (en) * | 1971-02-25 | 1978-07-31 | Robert R Chauvette | Method for producing derivatives of 3-methyl-delta up3-cephem-4-carboxylic acid |
| AU468437B2 (en) * | 1971-03-09 | 1976-01-15 | Takeda Chemical Industries, Ltd | Cephalosporin derivatives |
| US3865819A (en) * | 1972-05-03 | 1975-02-11 | Smithkline Corp | Substituted sulfonylacetamido cephalosporins |
| US3939266A (en) * | 1972-05-03 | 1976-02-17 | Smithkline Corporation | Substituted sulfonylacetamido cephalosporins |
| US3943131A (en) * | 1972-07-20 | 1976-03-09 | Smithkline Corporation | Trifluoromethylmercaptoacetamidocephalosporins |
| US3897422A (en) * | 1973-03-05 | 1975-07-29 | Squibb & Sons Inc | {8 (Azidomethyl)thio{9 acetylcephalosporins |
| FI771866A (de) * | 1976-06-28 | 1977-12-29 | Fujisawa Pharmaceutical Co | |
| US4409215A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical Co., Ltd. | 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof |
| FR2570702B1 (fr) * | 1984-09-27 | 1987-01-09 | Sanofi Sa | Derives des cephalosporines, procedes d'obtention et leur application a titre d'antibiotiques |
| CN1531539A (zh) * | 2001-04-19 | 2004-09-22 | ��ŷ�����¶����ǹɷ�����˾ | 用α-酮酸衍生物制备头孢烷酸衍生物的酶促方法 |
-
1968
- 1968-06-14 GB GB28528/68A patent/GB1279402A/en not_active Expired
-
1969
- 1969-06-13 NL NL6909100A patent/NL6909100A/xx unknown
- 1969-06-13 BE BE734533D patent/BE734533A/xx unknown
- 1969-06-13 IE IE820/69A patent/IE33997B1/xx unknown
- 1969-06-13 US US833149A patent/US3647788A/en not_active Expired - Lifetime
- 1969-06-13 FR FR6919762A patent/FR2010920A1/fr not_active Withdrawn
- 1969-06-13 AT AT563869A patent/AT306231B/de not_active IP Right Cessation
- 1969-06-13 DE DE19691930118 patent/DE1930118A1/de active Pending
- 1969-06-13 AT AT606871A patent/AT312798B/de not_active IP Right Cessation
- 1969-06-13 ZA ZA694201A patent/ZA694201B/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5248996B1 (de) * | 1971-01-29 | 1977-12-14 | Glaxo Lab Ltd | |
| JPS531280B1 (de) * | 1971-05-14 | 1978-01-17 |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1279402A (en) | 1972-06-28 |
| FR2010920A1 (de) | 1970-02-20 |
| DE1930118A1 (de) | 1969-12-18 |
| AT306231B (de) | 1973-03-26 |
| BE734533A (de) | 1969-12-15 |
| AT312798B (de) | 1974-01-25 |
| IE33997L (en) | 1969-12-14 |
| IE33997B1 (en) | 1975-01-08 |
| ZA694201B (en) | 1971-01-27 |
| US3647788A (en) | 1972-03-07 |